Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000382527 | SCV000341595 | uncertain significance | not provided | 2018-04-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001081285 | SCV001020899 | likely benign | Bethlem myopathy 1A | 2025-01-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000382527 | SCV001817196 | uncertain significance | not provided | 2024-10-02 | criteria provided, single submitter | clinical testing | In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 30564623) |
Ambry Genetics | RCV002521980 | SCV003579342 | likely benign | Inborn genetic diseases | 2022-01-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |